BioSpace News Archive

Eli Lilly and Company announced that tirzepatide achieved superior weight loss compared to placebo at 72 weeks of treatment in results from SURMOUNT-2.

Caris Life Sciences®, the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, announced that CARTI Cancer Center has joined the Caris Precision Oncology Alliance™.

Immunic, Inc. announced the appointment of Richard Rudick, M.D., a thought-leader in multiple sclerosis with decades of experience in the clinic, academia and industry, to its board of directors, effective April 26, 2023.

Quest Diagnostics and Haystack Oncology announced a definitive agreement for Quest to acquire Haystack in an all-cash equity transaction.

KalVista Pharmaceuticals, Inc. announced the acceptance of multiple abstracts at the 13th C1-inhibitor Deficiency & Angioedema Workshop taking place in Budapest, Hungary from May 4-7.

First Quarter 2023 Reflected Continued Strong Underlying Performance Across Key Growth Drivers, Particularly in Oncology and Vaccines.

Veru Inc. announced it will host a conference call and audio webcast on Thursday, May 11, 2023, at 8:00 a.m. ET to discuss its fiscal 2023 second quarter financial results and provide a business update.

Quest Diagnostics Incorporated, the world’s leading provider of diagnostic information services, announced financial results for the first quarter ended March 31, 2023.

Lilly defines New Products as select products launched since 2022, which currently consist of Jaypirca and Mounjaro.

Asensus Surgical, Inc., a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, announced that it plans to release 2023 first quarter financial and operating results after the market closes on Thursday, May 11, 2023.